Clinical Trials Browser

Terminated × Pancreatic Neoplasms × spartalizumab × Clear all

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT03207867 2024-10-09

A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Phase 2 Terminated

315 enrolled 73 charts

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Pancreatic Neoplasms, Spinocerebellar Degenerations, Triple Negative Breast Neoplasms

NCT03716596 2024-09-20

CISPD-2

Phase 1 Terminated

8 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01313416 2019-07-10

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

CISPD-2

Gemcitabine and CT-011 for Resected Pancreatic Cancer